BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.82 EUR
0.71%
Market Closed
Updated:
May 3, 2024
BRAIN Biotech AG
Selling, General & Administrative
|
BRAIN Biotech AG
Selling, General & Administrative Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Selling, General & Administrative
-€22.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Selling, General & Administrative
-€519.5m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Evonik Industries AG
XETRA:EVK
|
Selling, General & Administrative
-€2.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-2%
|
|
|
Covestro AG
XETRA:1COV
|
Selling, General & Administrative
-€1.9B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Selling, General & Administrative
-€153.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Selling, General & Administrative
-€951.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-11%
|
See Also
What is BRAIN Biotech AG's Selling, General & Administrative?
Selling, General & Administrative
-22.2m
EUR
-22.2m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Selling, General & Administrative amounts to -22.2m EUR.
What is BRAIN Biotech AG's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-2%
-2%
Over the last year, the Selling, General & Administrative growth was 1%. The average annual Selling, General & Administrative growth rates for BRAIN Biotech AG have been -5% over the past three years , -2% over the past five years .
You don't have any saved screeners yet
